drugset
Drugs / Live attenuated SA 14-14-2 Japanese Encephalitis vaccine
last change Jul 2017 re-read 3 minutes ago

Live attenuated SA 14-14-2 Japanese Encephalitis vaccine

Vaccine

Developed for
Japanese encephalitis
Investigated by
DFNet Research Inc. · PATH · Research Institute for Tropical Medicine · Syneos Health

Trials 1

today NCT02880865 · Ph 4
20172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT02880865 Oct 2016 → May 2017 Japanese encephalitis, measles, mumps infectious disease, rubella PATH Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Live attenuated SA 14-14-2 Japanese Encephalitis vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT02880865 ↗
Modality Vaccine “live, attenuated SA 14-14-2 JE vaccine” NCT02880865 ↗
Route Subcutaneous “administered by subcutaneous injection” NCT02880865 ↗